"Neurovations, a patient care and innovation company, was founded in 1992 by CEO Dr. Eric Grigsby. Today, Neurovations is a national leader in medical device and pharmaceutical innovation, clinical research, and a world-class education program focusing in pain and neuroscience. Dr. Grigsby is deeply connected to the healthcare community through our non-profit HealthRoots Foundation and to the Napa community through Rocca Family Vineyards, a producer of award-winning wines. Our unwavering mission is to inspire hope and to contribute to the health and well-being of our patients and communities through integrated clinical practice, research, and education."

During the past decade, Neurovations conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurovations" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Pacira CryoTech, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc." with 2 trials sponsored, "Bioness Inc" with 1 trials sponsored and "Cerephex Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

According to Clinical.Site data, the most researched conditions in "Neurovations" are "Chronic Pain" (5 trials), "Alzheimer Disease" (2 trials), "Back Pain" (2 trials), "Cancers" (1 trials) and "Facet Joint Pain" (1 trials). Many other conditions were trialed in "Neurovations" in a lesser frequency.

Most popular intervention types in "Neurovations" are "Device" (7 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Donanemab" (2 trials), "BSC approved SCS Trial Therapy w/ OMG" (1 trials), "Cryo-Touch III" (1 trials) and "Device: Cryo-Touch III Study treatment at Day 0." (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurovations" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Neurovations". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Neurovations, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Neurovations, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

Neurovations has several departments that took part in Clinical trials: "Neurovations (Napa Pain Institute)" - 2 trials